Rheumatoid Arthritis

Ρευματοειδής Αρθρίτιδα

 

Rheumatoid Arthritis is an Autoimmune Disease that mainly affects the joints of your body. The alteration of the synovial fluid leads to a painful inflammatory process over time that lead to chronic systemic inflammation.

Rheumatoid Arthritis is one of the hundred types of arthritis, with some of the most common types, being Osteoarthritis, Gout Arthritis and Psoriatic Arthritis.

 

Diagnosis of Real Causes & Treatment of Rheumatoid Arthritis

  • Gradual restoration of cellular function
  • Personalized therapeutic protocols, without chemical residues and excipients
  • Treating the real causes
  • Therapeutic formulas that work alone or in combination with any other medication
  • Adopting a Molecular / Therapeutic Nutrition Plan

 

All types have different causes, but the common factor is pain in the joints and eventually destruction.The disease affects 0.8 – 1% of all populations and is considered the second most common rheumatic diagnosis after Osteoarthritis.

It tends to affect two to three times more women than men.

 

Rheumatoid Arthritis Symptoms

Symptoms of Rheumatoid Arthritis mainly include pain, stiffness, swelling and redness around the joints. Patients tend to have symptoms in their hands, shoulders, elbows, hips and knees.

Usually, patients will have exacerbations followed by recessions, accompanied by a progressive deterioration of joints and damage caused by systemic inflammation.

The disease usually begins late in two thirds of patients and is often not diagnosed in the early stages.

Because of the systemic inflammatory nature of the Disease, additional symptoms include malaise, fatigue, loss of appetite and general aches.

 

Rheumatoid Arthritis & Immune System

Rheumatoid Arthritis is both an inflammatory arthritis and an Autoimmune Disorder.

In the early stages of the disease, before the inflammation of the joints occurs, a series of events occur in which the immune system loses the ability to distinguish between the tissues of the body (itself) and foreign tissue. This results in your immune system mistakenly attacking your own body, which in the case of RA is your joints, but it can also affect the surrounding tissues, including muscles, ligaments, tendons, and even other organs.

As the tissues begin to deteriorate due to repeated inflammation and immune activation, the joints may become deformed due to tissue damage.

Η λειτουργία της άρθρωσης μπορεί επίσης να ανασταλεί ή ακόμα και να σταματήσει στα προχωρημένα στάδια της νόσου.

 

Rheumatoid Arthritis Causes

Traditionally, Rheumatoid Arthritis is considered a Chronic Idiopathic Inflammatory Disorder, meaning the cause is unknown. There is evidence that the majority of patients are genetically predisposed to the Disease.

There are additional causes such as environmental toxins, food sensitivities, allergies, stress, trauma, infections, bacterial overgrowth (dysbiosis), leaky gut syndrome and hormonal imbalances.

 

Rheumatoid Arthritis Diagnosis

The doctor diagnoses Rheumatoid Arthritis through a physical examination, blood tests and possibly some imaging tests.

Clinically

  • Joint pain and morning stiffness (over 30 minutes) with history of previous episodes
  • Family history of Rheumatoid Arthritis
  • Characteristics of systemic flu and fatigue
  • Three or more swollen joints and sensitive areas (simultaneously)
  • Symmetric involvement in the joints in the hands and / or feet
  • Pain when pressure in the arms and legs (joints MCP or MCT)
  • resence of rheumatoid nodules (skin tightly pieces) that are in common pressure points on the body, usually on the elbows.

Blood Test

  • Rheumatoid Factor (RhF)
  • Erythrocyte Sedimentation Rate (ESR)
  • C-Reative Protein (CRP)
  • Antinuclear Antibody (ANA)
  • Anti-Parental Cell Antibody (APCA)
  • Cyclic Citrullinated Peptide Antibody (CCP)

Imaging tests

An X-Ray will reveal signs of bone damage in your hands and wrists, but this is usually observed at later stages of the Disease.

It is important to note that many patients will suffer for many years with chronic pain as they may not meet the “official” criteria for diagnosing RA in the early onset of the Disease.

 

Rheumatoid Arthritis Treatment

The usual treatment involves prescribing NSAIDs, steroids, and even drugs.

Unfortunately, these treatments only cover the Disease and long term use will usually cause unpleasant side effects, such as fatigue, rashes, intestinal discomfort and bleeding and anemia.

In addition, the effectiveness of treatment will decrease over time and may even aggravate the pain in the long run.

With the diagnosis of Rheumatoid Arthritis, drug therapy in collaboration with a rheumatologist is considered the gold standard of care.

Your doctor will usually prescribe traditionally used Disease-Modifying Anti-Rheumatic Drugs (DMARDs) such as Methotrexate or Plaquenil, which focus on slowing down the immune process, leading to reduced inflammation and slowing joint damage.

The newer biological drugs DMARDs focus on very specific immune cells that may be involved in the disease process, rather than targeting the entire immune complex. While these treatments are effective for many, they are at best comforting and do not provide treatment for the disease.

 

Rheumatoid Arthritis Causal Treatment

Effective treatment of Rheumatoid Arthritis can often be achieved through a combination of treatment approaches and management of traditional and Functional Medicine.

While medication is often needed during acute exacerbations, a skilled practitioner of Functional medicine can help you identify and treat the underlying causes of disease, to effectively eliminate the disease.

 

Possible causes may be:

  • Imbalance of DHEA / cortisol ratio / S lgA
  • Increased intestinal permeability
  • Bacterial parasitical infections
  • Hormonal imbalance
  • Fatty acid imbalance
  • Micronutrients and aminoacids deficiency
  • Oxidative stress

At the same time, always applying the right anti-inflammatory diet along with the appropriate physiotherapy helps to integrate the disease into a comprehensive therapeutic approach.

 

 

Dr. Nikoleta Koini, M.D.

Doctor of Functional, Preventive, Anti-ageing and Restorative Medicine.
Diplomate and Board Certified in Anti-aging, Preventive, Functional and Regenerative Medicine from A4M (American Academy in Antiaging Medicine).

 

 


References:

  • Verma MK, Sobha K. Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects. Inflamm Res. 2015;64(9):647-659. doi:1007/s00011-015-0843-8
  • Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-1587. doi:1002/art.39692
  • MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000;43(1):30-37. doi:1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B
  • Araki Y, Mimura T. The mechanisms underlying chronic inflammation in rheumatoid arthritis from the perspective of the epigenetic landscape. J Immunol Res. 2016;2016:6290682. doi:1155/2016/6290682
  • Glant TT, Mikecz K, Rauch TA. Epigenetics in the pathogenesis of rheumatoid arthritis. BMC Med. 2014;12:35. doi:1186/1741-7015-12-35
  • Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380-386. doi:1002/art.20018
  • Tracy A, Buckley CD, Raza K. Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start? Semin Immunopathol. 2017;39(4):423-435. doi:1007/s00281-017-0620-6
  • Rakieh C, Nam JL, Hunt L, et al. Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann Rheum Dis. 2015;74(9):1659-1666. doi:1136/annrheumdis-2014-205227
  • Ramos-Remus C, Castillo-Ortiz JD, Aguilar-Lozano L, et al. Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease. Arthritis Rheumatol. 2015;67(11):2837-2844. doi:1002/art.39297
  • Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2017;31(1):3-18. doi:1016/j.berh.2017.08.003
  • Harrison M, Spooner L, Bansback N, et al. Preventing rheumatoid arthritis: preferences for and predicted uptake of preventive treatments among high risk individuals. PLoS One. 2019;14(4):e0216075. doi:1371/journal.pone.0216075
  • Hunt L, Emery P. Defining populations at risk of rheumatoid arthritis: the first steps to prevention. Nat Rev Rheumatol. 2014;10(9):521-530. doi:1038/nrrheum.2014.82
  • Paul BJ, Kandy HI, Krishnan V. Pre-rheumatoid arthritis and its prevention. Eur J Rheumatol. 2017;4(2):161-165. doi:5152/eurjrheum.2017.16006
  • Gerlag DM, Norris JM, Tak PP. Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment. Rheumatology (Oxford). 2016;55(4):607-614. doi:1093/rheumatology/kev347
  • Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum. 1996;39(5):732-735. doi:1002/art.1780390504
  • Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003;62(9):835-841. doi:1136/ard.62.9.835
  • Hutchinson D, Shepstone L, Moots R, Lear JT, Lynch MP. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis. 2001;60(3):223-227. doi:1136/ard.60.3.223
  • Anderson R, Meyer PW, Ally MM, Tikly M. Smoking and air pollution as pro-inflammatory triggers for the development of rheumatoid arthritis. Nicotine Tob Res. 2016;18(7):1556-1565. doi:1093/ntr/ntw030
  • Kharlamova N, Jiang X, Sherina N, et al. Antibodies to Porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology. Arthritis Rheumatol. 2016;68(3):604-613. doi:1002/art.39491
  • Pretorius E, Akeredolu OO, Soma P, Kell DB. Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp Biol Med (Maywood). 2017;242(4):355-373. doi:1177/1535370216681549
  • Lu B, Hiraki LT, Sparks JA, et al. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study. Ann Rheum Dis. 2014;73(11):1914-1922. doi:1136/annrheumdis-2014-205459
  • Sparks JA, Chang SC, Nguyen US, et al. Weight change during the early rheumatoid arthritis period and risk of subsequent mortality in women with rheumatoid arthritis and matched comparators. Arthritis Rheumatol. 2018;70(1):18-29. doi:1002/art.40346
  • Baker JF, Von Feldt J, Mostoufi-Moab S, et al. Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014;66(11):1612-1618. doi:1002/acr.22328
  • Hanaoka BY, Ithurburn MP, Rigsbee CA, et al. Chronic inflammation in rheumatoid arthritis and mediators of skeletal muscle pathology and physical impairment: a review. Arthritis Care Res (Hoboken). 2019;71(2):173-177. doi:1002/acr.23775
  • Bärebring L, Winkvist A, Gjertsson I, Lindqvist HM. Poor dietary quality is associated with increased inflammation in Swedish patients with rheumatoid arthritis. Nutrients. 2018;10(10):E1535. doi:3390/nu10101535
  • Essouma M, Noubiap JJ. Is air pollution a risk factor for rheumatoid arthritis? J Inflamm (Lond). 2015;12:48. doi:1186/s12950-015-0092-1
  • Jung CR, Hsieh HY, Hwang BF. Air pollution as a potential determinant of rheumatoid arthritis: a population-based cohort study in Taiwan. 2017;28(Suppl 1):S54-S59. doi:10.1097/EDE.0000000000000732
  • Shin J, Lee J, Lee J, Ha EH. Association between exposure to ambient air pollution and rheumatoid arthritis in adults. Int J Environ Res Public Health. 2019;16(7):E1227. doi:3390/ijerph16071227
  • Sigaux J, Biton J, André E, Semerano L, Boissier MC. Air pollution as a determinant of rheumatoid arthritis. Joint Bone Spine. 2019;86(1):37-42. doi:1016/j.jbspin.2018.03.001
  • Araki Y, Mimura T. The mechanisms underlying chronic inflammation in rheumatoid arthritis from the perspective of the epigenetic landscape. J Immunol Res. 2016;2016:6290682. doi:1155/2016/6290682
  • Zaccardelli A, Friedlander HM, Ford JA, Sparks JA. Potential of lifestyle changes for reducing the risk of developing rheumatoid arthritis: is an ounce of prevention worth a pound of cure? Clin Ther. 2019;41(7):1323-1345. doi:1016/j.clinthera.2019.04.021
  • He J, Wang Y, Feng M, et al. Dietary intake and risk of rheumatoid arthritis—a cross section multicenter study. Clin Rheumatol. 2016;35(12):2901-2908. doi:1007/s10067-016-3383-x
  • Vadell AKE, Bärebring L, Hulander E, Gjertsson I, Lindqvist HM, Winkvist A. Anti-inflammatory diet in rheumatoid arthritis (ADIRA) – a randomized, controlled crossover trial indicating effects on disease activity. Am J Clin Nutri. 2020;111(6):1203-1213. doi:1093/ajcn/nqaa019
  • Philippou E, Nikiphorou E. Are we really what we eat? Nutrition and its role in the onset of rheumatoid arthritis. Autoimmun Rev. 2018;17(11):1074-1077. doi:1016/j.autrev.2018.05.009
  • Gioia C, Lucchino B, Tarsitano MG, Iannuccelli C, Di Franco M. Dietary habits and nutrition in rheumatoid arthritis: can diet influence disease development and clinical manifestations? Nutrients. 2020;12(5):1456. doi:3390/nu12051456
  • Asteriou E, Gkoutzourelas A, Mavropoulos A, Katsiari C, Sakkas LI, Bogdanos DP. Curcumin for the management of periodontitis and early ACPA-positive rheumatoid arthritis: killing two birds with one stone. 2018;10(7):E908. doi:10.3390/nu10070908